Co-Diagnostics Ownership | Who Owns Co-Diagnostics?

Overview Forecast RevenueFinancials Chart Transcripts

Co-Diagnostics Ownership Summary

Co-Diagnostics is owned by 2.18% institutional investors, 3.34% insiders, and 94.48% retail investors. Vanguard group is the largest institutional shareholder, holding 5.04% of CODX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 4.01% of its assets in Co-Diagnostics shares.

CODX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Co-Diagnostics	2.18%	3.34%	94.48%
Sector	Healthcare Stocks	35.34%	11.88%	52.77%
Industry	Medical Device Stocks	35.88%	10.92%	53.20%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	1.91M	5.04%	$322.64K
Blackrock	502.02K	1.68%	$627.53K
Virtu financial	126.52K	0.38%	$44.00K
Summit financial wealth advisors	40.00K	0.11%	$6.74K
Goldman sachs group	15.99K	0.05%	$11.99K
Wolverine trading	13.52K	0.04%	$9.46K
Citadel advisors	3.30K	0.01%	$4.13K
Global retirement partners	3.00K	0.01%	$506.00
Rhumbline advisers	972.00	0.00%	$1.22K
Cibc private wealth group	1.00K	0.00%	$280.00

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Virtu financial	126.52K	0.00%	$44.00K
Summit financial wealth advisors	40.00K	0.00%	$6.74K
National bank of canada /fi/	-	-	-
Peak6 investments	-	-	-
Engineers gate manager lp	-	-	-
Triton wealth management, p	-	-	-
Heritage wealth advisors	-	-	-
Blackrock	502.02K	-	$627.53K
Tower research capital llc (trc)	-	-	-
Renaissance	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	1.91M	-	203.17K
Virtu financial	126.52K	0.00%	100.90K
Summit financial wealth advisors	40.00K	0.00%	40.00K
Goldman sachs group	15.99K	-	15.99K
Wolverine trading	13.52K	-	13.52K

Top Sellers

Holder	Shares	% Assets	Change
Private advisory group	-	-	-1.18M
Renaissance	-	-	-730.32K
Geode capital management	-	-	-449.15K
Blackrock funding, inc. /de	-	-	-427.44K
Bridgeway capital management	-	-	-272.90K

New Positions

Holder	Shares	% Assets	Change	Value
Summit financial wealth advisors	40.00K	0.00%	40.00K	$6.74K
Goldman sachs group	15.99K	-	15.99K	$11.99K

Sold Out

Holder	Change
Qube research	-13.00
Bnp paribas arbitrage, snc	-60.00
Northwestern mutual wealth management	-100.00
Financial network wealth advisors	-100.00
National bank of canada /fi/	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	13	-59.38%	49,203	-99.11%	2	1.13%	6	-53.85%	7	-12.50%
Dec 31, 2025	21	-41.67%	5,368,444	-4.46%	14	4.92%	8	-27.27%	6	-33.33%
Sep 30, 2025	35	-2.78%	5,618,778	9.06%	16	6.57%	11	-15.38%	9	-
Jun 30, 2025	36	-7.69%	5,162,038	-11.65%	16	4.85%	13	-18.75%	9	12.50%
Mar 31, 2025	1	-97.67%	40,149	-99.30%	-	0.04%	1	-93.33%	-	-100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.28M	4.01%	-
Vanguard Total Stock Mkt Idx Inv	1.25M	3.45%	-27.29K
Vanguard Institutional Extnd Mkt Idx Tr	305.55K	0.84%	-139.23K
Bridgeway Ultra-Small Company	272.90K	0.81%	-
Fidelity Extended Market Index	318.40K	0.51%	161.85K
BlackRock Extended Equity Market K	72.43K	0.23%	-31.00
iShares Micro-Cap ETF	62.55K	0.19%	-
Spartan Total Market Index Pool E	43.70K	0.13%	-
Extended Equity Market Fund K	71.28K	0.11%	46.00
Fidelity Total Market Index	52.74K	0.08%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 20, 2023	Brown Brian Lee	Chief Financial Officer	Buy	$5.70K
Sep 08, 2021	Durenard Eugene	-	Sell	$20.91K
May 19, 2021	BENSON REED L	General Counsel	Sell	$830.39K
May 19, 2021	BENSON REED L	General Counsel	Sell	$8.53
May 19, 2021	BENSON REED L	General Counsel	Sell	$93.23K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	-	-
2024 Q2	-	-

CODX Ownership FAQ

Who Owns Co-Diagnostics?

Co-Diagnostics shareholders are primarily institutional investors at 2.18%, followed by 3.34% insiders and 94.48% retail investors. The average institutional ownership in Co-Diagnostics's industry, Medical Device Stocks, is 35.88%, which Co-Diagnostics falls below.

Who owns the most shares of Co-Diagnostics?

Co-Diagnostics’s largest shareholders are Vanguard group (1.91M shares, 5.04%), Blackrock (502.02K shares, 1.68%), and Virtu financial (126.52K shares, 0.38%). Together, they hold 7.10% of Co-Diagnostics’s total shares outstanding.

Does Blackrock own Co-Diagnostics?

Yes, BlackRock owns 1.68% of Co-Diagnostics, totaling 502.02K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 627.53K$. In the last quarter, BlackRock increased its holdings by 1.98K shares, a 0.40% change.

Who is Co-Diagnostics’s biggest shareholder by percentage of total assets invested?

Virtu financial is Co-Diagnostics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 126.52K Co-Diagnostics shares, valued at 44K$.

Who is the top mutual fund holder of Co-Diagnostics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Co-Diagnostics shares, with 4.01% of its total shares outstanding invested in 1.28M Co-Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools